Fariba Danesh, a director at Aehr Test Systems (NASDAQ:AEHR), executed a notable equity transaction on April 16, 2026, disposing of 8,000 shares of common stock at $82.63 per share, for gross proceeds of $661,040. On that same date she also exercised options to purchase 8,000 common shares at an exercise price of $2.25 per share, representing a stated exercise cost of $18,000.
Following those moves, Danesh's direct holdings in the company amount to 13,143 shares, a total that the company reports includes shares subject to unvested restricted stock units. The stock itself has experienced a dramatic run over the past year, rising 937 percent and trading at $83.86 at the time of reporting.
Independent analysis noted in company commentary flags valuation concerns at current prices. InvestingPro's assessment included observations that the stock appears overvalued at these levels, that it generally trades with high price volatility, and that the company has not been profitable over the trailing twelve months, with a negative EPS of $0.38. Investors are pointed to a Pro Research Report for a fuller breakdown of the platform's metrics.
Corporate developments at Aehr Test Systems during the same period highlight both commercial momentum and uneven near-term financial performance. The company announced a $41 million production order from a leading hyperscale customer for package-level burn-in of custom AI processor ASICs. The firm described the order as the largest in its history, covering Sonoma high-power package-level test and burn-in systems, burn-in modules, and device-specific sockets. Deliveries are expected to begin in fiscal 2027, with the first shipments scheduled to start on June 27, 2026.
Financial results for the company’s third fiscal quarter of 2026 were mixed. Reported earnings per share were negative $0.05, which was a smaller loss than the consensus forecast of negative $0.07. Revenue for the period came in at $10.3 million, short of the $10.8 million forecast. Offsetting the revenue shortfall, Aehr posted a record level of quarterly bookings at $37.2 million and reported an effective backlog in excess of $50 million.
Analyst responses to the booking momentum included price target increases from two firms. Freedom Broker raised its target to $61 and maintained a Hold rating, while Lake Street lifted its target to $56 and kept a Buy recommendation. Together, these analyst actions reflect attention to the company’s order intake and backlog even as near-term profitability remains negative.
Context and takeaway - The insider sale and option exercise by a director occurred against a backdrop of substantial share-price appreciation and a major commercial win for the company. The combination of a record production order and a growing backlog points to demand for Aehr’s burn-in systems, while quarterly results show mixed execution against revenue expectations and continued negative earnings.